Analyzing Bio-Rad Laboratories (NYSE:BIO) and TREES (OTCMKTS:CANN)

TREES (OTCMKTS:CANN) and Bio-Rad Laboratories (NYSE:BIO) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, institutional ownership, profitability and analyst recommendations.

Analyst Ratings

This is a summary of recent ratings and target prices for TREES and Bio-Rad Laboratories, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TREES	0	0	0	0	0.00
Bio-Rad Laboratories	1	2	3	0	2.33

Bio-Rad Laboratories has a consensus price target of $358.50, indicating a potential upside of 32.78%. Given Bio-Rad Laboratories’ stronger consensus rating and higher possible upside, analysts clearly believe Bio-Rad Laboratories is more favorable than TREES.

Profitability

This table compares TREES and Bio-Rad Laboratories’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
TREES	N/A	N/A	N/A
Bio-Rad Laboratories	29.42%	3.86%	2.70%

Insider and Institutional Ownership

11.3% of TREES shares are held by institutional investors. Comparatively, 65.2% of Bio-Rad Laboratories shares are held by institutional investors. 45.0% of TREES shares are held by insiders. Comparatively, 17.1% of Bio-Rad Laboratories shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility & Risk

TREES has a beta of -0.65, indicating that its share price is 165% less volatile than the S&P 500. Comparatively, Bio-Rad Laboratories has a beta of 1.18, indicating that its share price is 18% more volatile than the S&P 500.

Valuation & Earnings

This table compares TREES and Bio-Rad Laboratories”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TREES	$13.66 million	0.28	-$3.48 million	($0.02)	-1.66
Bio-Rad Laboratories	$2.58 billion	2.82	$759.90 million	$27.91	9.67

Bio-Rad Laboratories has higher revenue and earnings than TREES. TREES is trading at a lower price-to-earnings ratio than Bio-Rad Laboratories, indicating that it is currently the more affordable of the two stocks.

Summary

Bio-Rad Laboratories beats TREES on 13 of the 14 factors compared between the two stocks.

About TREES

Trees Corporation provides products and services to the regulated cannabis industry in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and retail dispensary store in Englewood, Colorado, as well as retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Lakewood, Colorado.

About Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.